ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Colorado » Internal Medicine

Top Internal Medicine Prescribers in Colorado

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ELENA CHEBANOVA MD

Internal Medicine

34,571

$2.38M

594
524 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

26%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $56

INDIRA MAHALINGAM M.D.

Internal Medicine

25,877

$1.88M

426
272 are 65+

24%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $56

MARK BERNTSEN MD

Internal Medicine

21,441

$1.1M

1084
906 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $56

LOAN PHAM M.D.

Internal Medicine

21,437

$110K

480
432 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$5
Average prescription price

Avg: $56

HELENA KANE

Internal Medicine

19,861

$55

352
306 are 65+

25%
patients receiving schedule two controlled substances

Avg: 8%

24%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$0
Average prescription price

Avg: $56

IGOR BORISOV MD

Internal Medicine

18,431

$1.16M

324
293 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $56

ROBERT FIERER M.D.

Internal Medicine

18,318

$1.27M

772
649 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $56

IRINA PINES MD

Internal Medicine

17,493

$1.06M

369
320 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $56

ELENA ANISIMOVA M.D.

Internal Medicine

17,232

$1.53M

283
246 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 24%

$89
Average prescription price

Avg: $56

JOHN HINER M.D.

Internal Medicine

16,625

$860K

387
349 are 65+

30%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $56

JOEL PARLIMENT

Internal Medicine

16,223

$835K

576
523 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $56

STEPHAN SHANE D.O.

Internal Medicine

14,999

$580K

1154
1076 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $56

KELLY JEONG MD

Internal Medicine

14,935

$588K

879
795 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $56

GENTRY DUNLOP MD

Internal Medicine

14,170

$773K

289
223 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $56

PETER SMITH MD

Internal Medicine

13,736

$844K

700
635 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $56

RUPINDER SINGH M.D.

Internal Medicine

13,576

$713K

615
538 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $56

JASON BARMORE MD

Internal Medicine

13,500

$576K

816
731 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $56

GEORGE BIRKS M.D.

Internal Medicine

13,411

$735K

635
554 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

21%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $56

DAVID PALMQUIST MD

Internal Medicine

13,299

$761K

861
760 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $56

ANTHONY ORTEGON

Internal Medicine

13,036

$899K

617
369 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $56

ROBERT VONRUEDEN MD

Internal Medicine

12,901

$527K

791
732 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $56

RENEE MICIELLI MD

Internal Medicine

12,767

$479K

930
821 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $56

KEVIN KEEFE DO

Internal Medicine

12,504

$621K

648
596 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $56

PATRICK MARTIN DO

Internal Medicine

12,286

$558K

713
630 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $56

MARY CLARK DO

Internal Medicine

12,264

$585K

290
255 are 65+

21%
patients receiving schedule two controlled substances

Avg: 8%

22%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank